Previous studies have indicated that mutp53 decreases chemosensitivity of glioblastoma to temozolomide by increasing the expression of MGMT (O6-methylguanine DNA-methyltransferase), this enzyme is involved in repair of DNA damage caused by temozolomide, thereby contributing to drug resistance (Wang et al., 2014). The gene discussed is MGMT; the disease is glioblastoma.